Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Vaccinations are effective in preventing infections; however, it is unknown if patients with chronic lymphocytic leukemia (CLL) who are treatment naïve (TN) or receiving Bruton tyrosine kinase inhibitors (BTKi's) respond to novel adjuvanted vaccines. Understanding the effect of BTKi's on h...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood
Главные авторы: Pleyer, Christopher, Ali, Mir A., Cohen, Jeffrey I., Tian, Xin, Soto, Susan, Ahn, Inhye E., Gaglione, Erika M., Nierman, Pia, Marti, Gerald E., Hesdorffer, Charles, Lotter, Jennifer, Superata, Jeanine, Wiestner, Adrian, Sun, Clare
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2021
Предметы:
Clinical Trials and Observations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7820878/
https://ncbi.nlm.nih.gov/pubmed/33259596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020008758
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы